IBI360

· Innovent Biologics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI360, covering 2024-10-17 to 2024-10-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia/Ib Clinical Trial of IBI360 Monotherapy or in Combination With Sintilimab and (or) Chemotherapy in Advanced or Metastatic Solid Tumors [Phase 1]

See pricing